| dc.contributor.advisor | Syce, James A. | |
| dc.contributor.author | Swead, Ramadan | |
| dc.date.accessioned | 2018-04-11T11:07:02Z | |
| dc.date.available | 2018-04-30T22:10:07Z | |
| dc.date.issued | 2018 | |
| dc.identifier.uri | http://hdl.handle.net/11394/5943 | |
| dc.description | Magister Scientiae - MSc (Pharmacy Administration and Policy Regulation) | |
| dc.description.abstract | The prevalence of diabetes mellitus is increasing worldwide and it is becoming a significant
medical problem in low- and middle-income countries. The condition can be controlled
with a lifelong commitment to blood sugar monitoring, weight management, proper
nutrition, exercise, and pharmacotherapy. Additional new pharmacotherapies are however
needed to combat the increased prevalence and various traditionally used herbs, such as
Sutherlandia frutescens (S, frutescens), are being advocated to supplement the management
of type 2 diabetes mellitus. However, the clinical efficacy of S. frutescens in the
management of type 2 diabetes mellitus has not yet been scientifically established. | |
| dc.language.iso | en | |
| dc.publisher | University of the Western Cape | |
| dc.title | The development of a study protocol, and ethics and regulatory approval
documentation, for evaluation of clinical efficacy of Sutherlandia frutescens in adult
type-2 diabetics | |
| dc.rights.holder | University of the Western Cape | |
